nodes	percent_of_prediction	percent_of_DWPC	metapath
Vismodegib—Sulfasalazine—ulcerative colitis	0.424	1	CrCtD
Vismodegib—Sulfasalazine—Olsalazine—ulcerative colitis	0.131	0.508	CrCrCtD
Vismodegib—Sulfasalazine—Balsalazide—ulcerative colitis	0.0991	0.385	CrCrCtD
Vismodegib—ALB—ulcerative colitis	0.0627	0.512	CbGaD
Vismodegib—ABCB1—ulcerative colitis	0.0599	0.488	CbGaD
Vismodegib—Sulfapyridine—Sulfasalazine—ulcerative colitis	0.0276	0.107	CrCrCtD
Vismodegib—ABCG2—Sulfasalazine—ulcerative colitis	0.0125	0.0837	CbGbCtD
Vismodegib—ABCG2—Hydrocortisone—ulcerative colitis	0.01	0.0672	CbGbCtD
Vismodegib—CYP2C8—Nicotine—ulcerative colitis	0.00857	0.0573	CbGbCtD
Vismodegib—CYP3A4—Budesonide—ulcerative colitis	0.00799	0.0534	CbGbCtD
Vismodegib—CYP2C8—Cholecalciferol—ulcerative colitis	0.00769	0.0514	CbGbCtD
Vismodegib—CYP2C19—Nicotine—ulcerative colitis	0.00719	0.0481	CbGbCtD
Vismodegib—ALB—Prednisone—ulcerative colitis	0.0069	0.0461	CbGbCtD
Vismodegib—CYP2C19—Cholecalciferol—ulcerative colitis	0.00645	0.0432	CbGbCtD
Vismodegib—ABCG2—Dexamethasone—ulcerative colitis	0.00624	0.0418	CbGbCtD
Vismodegib—CYP2C9—Nicotine—ulcerative colitis	0.00598	0.04	CbGbCtD
Vismodegib—ABCB1—Methylprednisolone—ulcerative colitis	0.00595	0.0398	CbGbCtD
Vismodegib—CYP2C9—Cholecalciferol—ulcerative colitis	0.00536	0.0359	CbGbCtD
Vismodegib—CYP2C8—Hydrocortisone—ulcerative colitis	0.00535	0.0358	CbGbCtD
Vismodegib—CYP2C19—Prednisone—ulcerative colitis	0.00447	0.0299	CbGbCtD
Vismodegib—ABCB1—Betamethasone—ulcerative colitis	0.00387	0.0259	CbGbCtD
Vismodegib—ABCB1—Prednisolone—ulcerative colitis	0.00382	0.0256	CbGbCtD
Vismodegib—ABCB1—Hydrocortisone—ulcerative colitis	0.00362	0.0242	CbGbCtD
Vismodegib—ABCB1—Prednisone—ulcerative colitis	0.00361	0.0241	CbGbCtD
Vismodegib—CYP3A4—Methylprednisolone—ulcerative colitis	0.00357	0.0239	CbGbCtD
Vismodegib—CYP3A4—Nicotine—ulcerative colitis	0.00348	0.0233	CbGbCtD
Vismodegib—CYP2C8—Dexamethasone—ulcerative colitis	0.00333	0.0223	CbGbCtD
Vismodegib—CYP3A4—Cholecalciferol—ulcerative colitis	0.00312	0.0209	CbGbCtD
Vismodegib—CYP2C19—Dexamethasone—ulcerative colitis	0.00279	0.0187	CbGbCtD
Vismodegib—CYP3A4—Triamcinolone—ulcerative colitis	0.0027	0.0181	CbGbCtD
Vismodegib—CYP2C9—Dexamethasone—ulcerative colitis	0.00232	0.0155	CbGbCtD
Vismodegib—CYP3A4—Betamethasone—ulcerative colitis	0.00232	0.0155	CbGbCtD
Vismodegib—CYP3A4—Prednisolone—ulcerative colitis	0.00229	0.0153	CbGbCtD
Vismodegib—ABCB1—Dexamethasone—ulcerative colitis	0.00225	0.0151	CbGbCtD
Vismodegib—CYP3A4—Hydrocortisone—ulcerative colitis	0.00217	0.0145	CbGbCtD
Vismodegib—CYP3A4—Prednisone—ulcerative colitis	0.00216	0.0145	CbGbCtD
Vismodegib—ORM1—bile—ulcerative colitis	0.00152	0.368	CbGeAlD
Vismodegib—CYP3A4—Dexamethasone—ulcerative colitis	0.00135	0.00903	CbGbCtD
Vismodegib—SHH—epithelium—ulcerative colitis	0.000716	0.173	CbGeAlD
Vismodegib—SHH—digestive system—ulcerative colitis	0.000545	0.132	CbGeAlD
Vismodegib—Neoplasm malignant—Azathioprine—ulcerative colitis	0.000292	0.0121	CcSEcCtD
Vismodegib—Sulfasalazine—PPARG—ulcerative colitis	0.000287	0.249	CrCbGaD
Vismodegib—SMO—liver—ulcerative colitis	0.000284	0.0686	CbGeAlD
Vismodegib—Phosphatase alkaline increased—Budesonide—ulcerative colitis	0.00028	0.0116	CcSEcCtD
Vismodegib—Breast disorder—Mercaptopurine—ulcerative colitis	0.000275	0.0114	CcSEcCtD
Vismodegib—Abdominal pain upper—Nicotine—ulcerative colitis	0.000269	0.0112	CcSEcCtD
Vismodegib—Amenorrhoea—Mesalazine—ulcerative colitis	0.000259	0.0107	CcSEcCtD
Vismodegib—Hepatic enzyme increased—Mesalazine—ulcerative colitis	0.00024	0.00998	CcSEcCtD
Vismodegib—Blood alkaline phosphatase increased—Budesonide—ulcerative colitis	0.000233	0.00969	CcSEcCtD
Vismodegib—Tolvaptan—ABCB1—ulcerative colitis	0.000231	0.2	CrCbGaD
Vismodegib—Musculoskeletal pain—Mesalazine—ulcerative colitis	0.00023	0.00956	CcSEcCtD
Vismodegib—Phosphatase alkaline increased—Mesalazine—ulcerative colitis	0.000227	0.00944	CcSEcCtD
Vismodegib—Blood urea increased—Mesalazine—ulcerative colitis	0.000215	0.00891	CcSEcCtD
Vismodegib—Sulfasalazine—PTGS1—ulcerative colitis	0.000212	0.184	CrCbGaD
Vismodegib—Etoricoxib—PTGS2—ulcerative colitis	0.000206	0.178	CrCbGaD
Vismodegib—Blood alkaline phosphatase increased—Mesalazine—ulcerative colitis	0.00019	0.00788	CcSEcCtD
Vismodegib—Alopecia—Mercaptopurine—ulcerative colitis	0.000186	0.00772	CcSEcCtD
Vismodegib—Abdominal pain upper—Budesonide—ulcerative colitis	0.000185	0.0077	CcSEcCtD
Vismodegib—Hypokalaemia—Budesonide—ulcerative colitis	0.000185	0.00767	CcSEcCtD
Vismodegib—Amenorrhoea—Hydrocortisone—ulcerative colitis	0.000184	0.00764	CcSEcCtD
Vismodegib—Breast disorder—Budesonide—ulcerative colitis	0.000183	0.00761	CcSEcCtD
Vismodegib—Malnutrition—Mercaptopurine—ulcerative colitis	0.000183	0.0076	CcSEcCtD
Vismodegib—Dysgeusia—Nicotine—ulcerative colitis	0.000174	0.00722	CcSEcCtD
Vismodegib—Amenorrhoea—Methylprednisolone—ulcerative colitis	0.000173	0.00718	CcSEcCtD
Vismodegib—Back pain—Nicotine—ulcerative colitis	0.000172	0.00713	CcSEcCtD
Vismodegib—Muscle spasms—Nicotine—ulcerative colitis	0.000171	0.00708	CcSEcCtD
Vismodegib—Amenorrhoea—Betamethasone—ulcerative colitis	0.000157	0.00653	CcSEcCtD
Vismodegib—Amenorrhoea—Dexamethasone—ulcerative colitis	0.000157	0.00653	CcSEcCtD
Vismodegib—Arthralgia—Mercaptopurine—ulcerative colitis	0.000156	0.00647	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—ulcerative colitis	0.000155	0.00643	CcSEcCtD
Vismodegib—Arthralgia—Nicotine—ulcerative colitis	0.000151	0.00627	CcSEcCtD
Vismodegib—Myalgia—Nicotine—ulcerative colitis	0.000151	0.00627	CcSEcCtD
Vismodegib—Abdominal pain upper—Mesalazine—ulcerative colitis	0.000151	0.00626	CcSEcCtD
Vismodegib—Breast disorder—Mesalazine—ulcerative colitis	0.000149	0.00619	CcSEcCtD
Vismodegib—Aspartate aminotransferase increased—Mesalazine—ulcerative colitis	0.000149	0.00617	CcSEcCtD
Vismodegib—Skin disorder—Mercaptopurine—ulcerative colitis	0.000145	0.00603	CcSEcCtD
Vismodegib—Nervous system disorder—Nicotine—ulcerative colitis	0.000142	0.0059	CcSEcCtD
Vismodegib—Connective tissue disorder—Budesonide—ulcerative colitis	0.000138	0.00573	CcSEcCtD
Vismodegib—Amenorrhoea—Prednisone—ulcerative colitis	0.000137	0.00568	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Mercaptopurine—ulcerative colitis	0.000136	0.00565	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Nicotine—ulcerative colitis	0.000132	0.00548	CcSEcCtD
Vismodegib—Decreased appetite—Mercaptopurine—ulcerative colitis	0.00013	0.00539	CcSEcCtD
Vismodegib—Weight decreased—Mesalazine—ulcerative colitis	0.000129	0.00536	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Mercaptopurine—ulcerative colitis	0.000129	0.00536	CcSEcCtD
Vismodegib—Dyspepsia—Nicotine—ulcerative colitis	0.000128	0.00529	CcSEcCtD
Vismodegib—Blood alkaline phosphatase increased—Methylprednisolone—ulcerative colitis	0.000127	0.00526	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Nicotine—ulcerative colitis	0.000125	0.00519	CcSEcCtD
Vismodegib—Fatigue—Nicotine—ulcerative colitis	0.000125	0.00518	CcSEcCtD
Vismodegib—Alopecia—Budesonide—ulcerative colitis	0.000124	0.00515	CcSEcCtD
Vismodegib—ORM1—liver—ulcerative colitis	0.000124	0.03	CbGeAlD
Vismodegib—Pain—Nicotine—ulcerative colitis	0.000124	0.00514	CcSEcCtD
Vismodegib—Constipation—Nicotine—ulcerative colitis	0.000124	0.00514	CcSEcCtD
Vismodegib—Malnutrition—Budesonide—ulcerative colitis	0.000122	0.00507	CcSEcCtD
Vismodegib—Sulfasalazine—PTGS2—ulcerative colitis	0.000121	0.105	CrCbGaD
Vismodegib—Dysgeusia—Budesonide—ulcerative colitis	0.00012	0.00497	CcSEcCtD
Vismodegib—Gastrointestinal pain—Nicotine—ulcerative colitis	0.000118	0.00492	CcSEcCtD
Vismodegib—Back pain—Budesonide—ulcerative colitis	0.000118	0.00491	CcSEcCtD
Vismodegib—CYP2C19—digestive system—ulcerative colitis	0.000118	0.0284	CbGeAlD
Vismodegib—Muscle spasms—Budesonide—ulcerative colitis	0.000118	0.00488	CcSEcCtD
Vismodegib—Abdominal pain—Nicotine—ulcerative colitis	0.000115	0.00475	CcSEcCtD
Vismodegib—Connective tissue disorder—Mesalazine—ulcerative colitis	0.000112	0.00466	CcSEcCtD
Vismodegib—Alopecia—Azathioprine—ulcerative colitis	0.000111	0.0046	CcSEcCtD
Vismodegib—ALB—liver—ulcerative colitis	0.000109	0.0263	CbGeAlD
Vismodegib—Abdominal pain upper—Hydrocortisone—ulcerative colitis	0.000107	0.00445	CcSEcCtD
Vismodegib—Hypokalaemia—Hydrocortisone—ulcerative colitis	0.000107	0.00444	CcSEcCtD
Vismodegib—Arthralgia—Budesonide—ulcerative colitis	0.000104	0.00432	CcSEcCtD
Vismodegib—Myalgia—Budesonide—ulcerative colitis	0.000104	0.00432	CcSEcCtD
Vismodegib—Asthenia—Nicotine—ulcerative colitis	0.000104	0.00431	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Budesonide—ulcerative colitis	0.000103	0.00429	CcSEcCtD
Vismodegib—Pruritus—Nicotine—ulcerative colitis	0.000102	0.00425	CcSEcCtD
Vismodegib—Diarrhoea—Mercaptopurine—ulcerative colitis	0.000102	0.00425	CcSEcCtD
Vismodegib—Alopecia—Mesalazine—ulcerative colitis	0.000101	0.00419	CcSEcCtD
Vismodegib—Breast disorder—Methylprednisolone—ulcerative colitis	9.97e-05	0.00414	CcSEcCtD
Vismodegib—Diarrhoea—Nicotine—ulcerative colitis	9.91e-05	0.00411	CcSEcCtD
Vismodegib—Nervous system disorder—Budesonide—ulcerative colitis	9.78e-05	0.00406	CcSEcCtD
Vismodegib—Dysgeusia—Mesalazine—ulcerative colitis	9.74e-05	0.00404	CcSEcCtD
Vismodegib—Sorafenib—ABCB1—ulcerative colitis	9.72e-05	0.0843	CrCbGaD
Vismodegib—Skin disorder—Budesonide—ulcerative colitis	9.69e-05	0.00402	CcSEcCtD
Vismodegib—Back pain—Mesalazine—ulcerative colitis	9.62e-05	0.00399	CcSEcCtD
Vismodegib—Muscle spasms—Mesalazine—ulcerative colitis	9.56e-05	0.00397	CcSEcCtD
Vismodegib—Vomiting—Mercaptopurine—ulcerative colitis	9.51e-05	0.00395	CcSEcCtD
Vismodegib—Rash—Mercaptopurine—ulcerative colitis	9.43e-05	0.00391	CcSEcCtD
Vismodegib—Dermatitis—Mercaptopurine—ulcerative colitis	9.42e-05	0.00391	CcSEcCtD
Vismodegib—Myalgia—Azathioprine—ulcerative colitis	9.29e-05	0.00386	CcSEcCtD
Vismodegib—Arthralgia—Azathioprine—ulcerative colitis	9.29e-05	0.00386	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—ulcerative colitis	9.23e-05	0.00383	CcSEcCtD
Vismodegib—Vomiting—Nicotine—ulcerative colitis	9.21e-05	0.00382	CcSEcCtD
Vismodegib—Weight decreased—Hydrocortisone—ulcerative colitis	9.18e-05	0.00381	CcSEcCtD
Vismodegib—Rash—Nicotine—ulcerative colitis	9.13e-05	0.00379	CcSEcCtD
Vismodegib—Hypokalaemia—Betamethasone—ulcerative colitis	9.13e-05	0.00379	CcSEcCtD
Vismodegib—Hypokalaemia—Dexamethasone—ulcerative colitis	9.13e-05	0.00379	CcSEcCtD
Vismodegib—Dermatitis—Nicotine—ulcerative colitis	9.13e-05	0.00379	CcSEcCtD
Vismodegib—CYP2C9—digestive system—ulcerative colitis	9.11e-05	0.022	CbGeAlD
Vismodegib—Musculoskeletal discomfort—Budesonide—ulcerative colitis	9.09e-05	0.00377	CcSEcCtD
Vismodegib—Nausea—Mercaptopurine—ulcerative colitis	8.88e-05	0.00369	CcSEcCtD
Vismodegib—Dyspepsia—Budesonide—ulcerative colitis	8.78e-05	0.00365	CcSEcCtD
Vismodegib—CYP2C19—liver—ulcerative colitis	8.76e-05	0.0212	CbGeAlD
Vismodegib—Decreased appetite—Budesonide—ulcerative colitis	8.67e-05	0.0036	CcSEcCtD
Vismodegib—Skin disorder—Azathioprine—ulcerative colitis	8.65e-05	0.00359	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Budesonide—ulcerative colitis	8.61e-05	0.00358	CcSEcCtD
Vismodegib—Nausea—Nicotine—ulcerative colitis	8.6e-05	0.00357	CcSEcCtD
Vismodegib—Fatigue—Budesonide—ulcerative colitis	8.6e-05	0.00357	CcSEcCtD
Vismodegib—Constipation—Budesonide—ulcerative colitis	8.53e-05	0.00354	CcSEcCtD
Vismodegib—Pain—Budesonide—ulcerative colitis	8.53e-05	0.00354	CcSEcCtD
Vismodegib—Myalgia—Mesalazine—ulcerative colitis	8.46e-05	0.00351	CcSEcCtD
Vismodegib—Arthralgia—Mesalazine—ulcerative colitis	8.46e-05	0.00351	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—ulcerative colitis	8.41e-05	0.00349	CcSEcCtD
Vismodegib—Gastrointestinal pain—Budesonide—ulcerative colitis	8.16e-05	0.00339	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Azathioprine—ulcerative colitis	8.12e-05	0.00337	CcSEcCtD
Vismodegib—Connective tissue disorder—Hydrocortisone—ulcerative colitis	7.98e-05	0.00331	CcSEcCtD
Vismodegib—Nervous system disorder—Mesalazine—ulcerative colitis	7.96e-05	0.0033	CcSEcCtD
Vismodegib—Hypokalaemia—Prednisone—ulcerative colitis	7.95e-05	0.0033	CcSEcCtD
Vismodegib—Abdominal pain—Budesonide—ulcerative colitis	7.89e-05	0.00327	CcSEcCtD
Vismodegib—Skin disorder—Mesalazine—ulcerative colitis	7.88e-05	0.00327	CcSEcCtD
Vismodegib—Weight decreased—Dexamethasone—ulcerative colitis	7.84e-05	0.00326	CcSEcCtD
Vismodegib—Weight decreased—Betamethasone—ulcerative colitis	7.84e-05	0.00326	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Azathioprine—ulcerative colitis	7.69e-05	0.00319	CcSEcCtD
Vismodegib—CYP2C8—liver—ulcerative colitis	7.64e-05	0.0185	CbGeAlD
Vismodegib—Connective tissue disorder—Methylprednisolone—ulcerative colitis	7.5e-05	0.00311	CcSEcCtD
Vismodegib—ABCG2—liver—ulcerative colitis	7.43e-05	0.018	CbGeAlD
Vismodegib—Musculoskeletal discomfort—Mesalazine—ulcerative colitis	7.39e-05	0.00307	CcSEcCtD
Vismodegib—Gastrointestinal pain—Azathioprine—ulcerative colitis	7.28e-05	0.00302	CcSEcCtD
Vismodegib—Asthenia—Budesonide—ulcerative colitis	7.16e-05	0.00297	CcSEcCtD
Vismodegib—Dyspepsia—Mesalazine—ulcerative colitis	7.14e-05	0.00296	CcSEcCtD
Vismodegib—Malnutrition—Hydrocortisone—ulcerative colitis	7.07e-05	0.00293	CcSEcCtD
Vismodegib—Pruritus—Budesonide—ulcerative colitis	7.06e-05	0.00293	CcSEcCtD
Vismodegib—Decreased appetite—Mesalazine—ulcerative colitis	7.05e-05	0.00293	CcSEcCtD
Vismodegib—Abdominal pain—Azathioprine—ulcerative colitis	7.04e-05	0.00292	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Mesalazine—ulcerative colitis	7e-05	0.00291	CcSEcCtD
Vismodegib—Fatigue—Mesalazine—ulcerative colitis	7e-05	0.0029	CcSEcCtD
Vismodegib—CYP3A4—digestive system—ulcerative colitis	6.95e-05	0.0168	CbGeAlD
Vismodegib—Constipation—Mesalazine—ulcerative colitis	6.94e-05	0.00288	CcSEcCtD
Vismodegib—Pain—Mesalazine—ulcerative colitis	6.94e-05	0.00288	CcSEcCtD
Vismodegib—Weight decreased—Prednisone—ulcerative colitis	6.83e-05	0.00284	CcSEcCtD
Vismodegib—Diarrhoea—Budesonide—ulcerative colitis	6.83e-05	0.00283	CcSEcCtD
Vismodegib—CYP2C9—liver—ulcerative colitis	6.79e-05	0.0164	CbGeAlD
Vismodegib—Malnutrition—Methylprednisolone—ulcerative colitis	6.64e-05	0.00276	CcSEcCtD
Vismodegib—Gastrointestinal pain—Mesalazine—ulcerative colitis	6.63e-05	0.00275	CcSEcCtD
Vismodegib—Dysgeusia—Triamcinolone—ulcerative colitis	6.52e-05	0.00271	CcSEcCtD
Vismodegib—ABCB1—epithelium—ulcerative colitis	6.47e-05	0.0156	CbGeAlD
Vismodegib—Back pain—Triamcinolone—ulcerative colitis	6.44e-05	0.00267	CcSEcCtD
Vismodegib—Abdominal pain—Mesalazine—ulcerative colitis	6.41e-05	0.00266	CcSEcCtD
Vismodegib—Vomiting—Budesonide—ulcerative colitis	6.34e-05	0.00263	CcSEcCtD
Vismodegib—Rash—Budesonide—ulcerative colitis	6.29e-05	0.00261	CcSEcCtD
Vismodegib—Dermatitis—Budesonide—ulcerative colitis	6.28e-05	0.00261	CcSEcCtD
Vismodegib—Alopecia—Dexamethasone—ulcerative colitis	6.13e-05	0.00255	CcSEcCtD
Vismodegib—Alopecia—Betamethasone—ulcerative colitis	6.13e-05	0.00255	CcSEcCtD
Vismodegib—Diarrhoea—Azathioprine—ulcerative colitis	6.09e-05	0.00253	CcSEcCtD
Vismodegib—Myalgia—Hydrocortisone—ulcerative colitis	6.02e-05	0.0025	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	5.98e-05	0.00248	CcSEcCtD
Vismodegib—Connective tissue disorder—Prednisone—ulcerative colitis	5.94e-05	0.00246	CcSEcCtD
Vismodegib—Nausea—Budesonide—ulcerative colitis	5.93e-05	0.00246	CcSEcCtD
Vismodegib—Asthenia—Mesalazine—ulcerative colitis	5.82e-05	0.00242	CcSEcCtD
Vismodegib—Pruritus—Mesalazine—ulcerative colitis	5.74e-05	0.00238	CcSEcCtD
Vismodegib—Myalgia—Triamcinolone—ulcerative colitis	5.67e-05	0.00235	CcSEcCtD
Vismodegib—Vomiting—Azathioprine—ulcerative colitis	5.66e-05	0.00235	CcSEcCtD
Vismodegib—Nervous system disorder—Hydrocortisone—ulcerative colitis	5.66e-05	0.00235	CcSEcCtD
Vismodegib—Arthralgia—Methylprednisolone—ulcerative colitis	5.65e-05	0.00235	CcSEcCtD
Vismodegib—Myalgia—Methylprednisolone—ulcerative colitis	5.65e-05	0.00235	CcSEcCtD
Vismodegib—Rash—Azathioprine—ulcerative colitis	5.62e-05	0.00233	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	5.62e-05	0.00233	CcSEcCtD
Vismodegib—Dermatitis—Azathioprine—ulcerative colitis	5.61e-05	0.00233	CcSEcCtD
Vismodegib—Skin disorder—Hydrocortisone—ulcerative colitis	5.6e-05	0.00233	CcSEcCtD
Vismodegib—Diarrhoea—Mesalazine—ulcerative colitis	5.55e-05	0.0023	CcSEcCtD
Vismodegib—Alopecia—Prednisone—ulcerative colitis	5.34e-05	0.00222	CcSEcCtD
Vismodegib—Nervous system disorder—Methylprednisolone—ulcerative colitis	5.32e-05	0.00221	CcSEcCtD
Vismodegib—Nausea—Azathioprine—ulcerative colitis	5.29e-05	0.0022	CcSEcCtD
Vismodegib—Skin disorder—Methylprednisolone—ulcerative colitis	5.27e-05	0.00219	CcSEcCtD
Vismodegib—Malnutrition—Prednisone—ulcerative colitis	5.26e-05	0.00218	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	5.26e-05	0.00218	CcSEcCtD
Vismodegib—CYP3A4—liver—ulcerative colitis	5.18e-05	0.0125	CbGeAlD
Vismodegib—Vomiting—Mesalazine—ulcerative colitis	5.16e-05	0.00214	CcSEcCtD
Vismodegib—Myalgia—Betamethasone—ulcerative colitis	5.14e-05	0.00213	CcSEcCtD
Vismodegib—Myalgia—Dexamethasone—ulcerative colitis	5.14e-05	0.00213	CcSEcCtD
Vismodegib—Rash—Mesalazine—ulcerative colitis	5.12e-05	0.00212	CcSEcCtD
Vismodegib—Dermatitis—Mesalazine—ulcerative colitis	5.11e-05	0.00212	CcSEcCtD
Vismodegib—Dyspepsia—Hydrocortisone—ulcerative colitis	5.08e-05	0.00211	CcSEcCtD
Vismodegib—Pain—Prednisolone—ulcerative colitis	5.05e-05	0.0021	CcSEcCtD
Vismodegib—Decreased appetite—Hydrocortisone—ulcerative colitis	5.02e-05	0.00208	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	4.98e-05	0.00207	CcSEcCtD
Vismodegib—ABCB1—lymphoid tissue—ulcerative colitis	4.98e-05	0.012	CbGeAlD
Vismodegib—Fatigue—Hydrocortisone—ulcerative colitis	4.97e-05	0.00206	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	4.95e-05	0.00205	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	4.94e-05	0.00205	CcSEcCtD
Vismodegib—Pain—Hydrocortisone—ulcerative colitis	4.93e-05	0.00205	CcSEcCtD
Vismodegib—ABCB1—digestive system—ulcerative colitis	4.92e-05	0.0119	CbGeAlD
Vismodegib—Nervous system disorder—Betamethasone—ulcerative colitis	4.83e-05	0.00201	CcSEcCtD
Vismodegib—Nervous system disorder—Dexamethasone—ulcerative colitis	4.83e-05	0.00201	CcSEcCtD
Vismodegib—Nausea—Mesalazine—ulcerative colitis	4.82e-05	0.002	CcSEcCtD
Vismodegib—Dyspepsia—Triamcinolone—ulcerative colitis	4.78e-05	0.00199	CcSEcCtD
Vismodegib—Dyspepsia—Methylprednisolone—ulcerative colitis	4.77e-05	0.00198	CcSEcCtD
Vismodegib—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	4.72e-05	0.00196	CcSEcCtD
Vismodegib—Fatigue—Triamcinolone—ulcerative colitis	4.68e-05	0.00194	CcSEcCtD
Vismodegib—Fatigue—Methylprednisolone—ulcerative colitis	4.67e-05	0.00194	CcSEcCtD
Vismodegib—Pain—Triamcinolone—ulcerative colitis	4.65e-05	0.00193	CcSEcCtD
Vismodegib—Abdominal pain—Hydrocortisone—ulcerative colitis	4.56e-05	0.00189	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	4.49e-05	0.00186	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	4.49e-05	0.00186	CcSEcCtD
Vismodegib—Arthralgia—Prednisone—ulcerative colitis	4.48e-05	0.00186	CcSEcCtD
Vismodegib—Myalgia—Prednisone—ulcerative colitis	4.48e-05	0.00186	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	4.45e-05	0.00185	CcSEcCtD
Vismodegib—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	4.43e-05	0.00184	CcSEcCtD
Vismodegib—Dyspepsia—Betamethasone—ulcerative colitis	4.34e-05	0.0018	CcSEcCtD
Vismodegib—Dyspepsia—Dexamethasone—ulcerative colitis	4.34e-05	0.0018	CcSEcCtD
Vismodegib—Abdominal pain—Methylprednisolone—ulcerative colitis	4.29e-05	0.00178	CcSEcCtD
Vismodegib—Decreased appetite—Betamethasone—ulcerative colitis	4.29e-05	0.00178	CcSEcCtD
Vismodegib—Decreased appetite—Dexamethasone—ulcerative colitis	4.29e-05	0.00178	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	4.26e-05	0.00177	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Betamethasone—ulcerative colitis	4.26e-05	0.00177	CcSEcCtD
Vismodegib—Fatigue—Dexamethasone—ulcerative colitis	4.25e-05	0.00176	CcSEcCtD
Vismodegib—Fatigue—Betamethasone—ulcerative colitis	4.25e-05	0.00176	CcSEcCtD
Vismodegib—Pain—Dexamethasone—ulcerative colitis	4.22e-05	0.00175	CcSEcCtD
Vismodegib—Pain—Betamethasone—ulcerative colitis	4.22e-05	0.00175	CcSEcCtD
Vismodegib—Nervous system disorder—Prednisone—ulcerative colitis	4.21e-05	0.00175	CcSEcCtD
Vismodegib—Skin disorder—Prednisone—ulcerative colitis	4.17e-05	0.00173	CcSEcCtD
Vismodegib—Asthenia—Hydrocortisone—ulcerative colitis	4.14e-05	0.00172	CcSEcCtD
Vismodegib—Pruritus—Hydrocortisone—ulcerative colitis	4.08e-05	0.00169	CcSEcCtD
Vismodegib—Gastrointestinal pain—Betamethasone—ulcerative colitis	4.03e-05	0.00167	CcSEcCtD
Vismodegib—Gastrointestinal pain—Dexamethasone—ulcerative colitis	4.03e-05	0.00167	CcSEcCtD
Vismodegib—Diarrhoea—Hydrocortisone—ulcerative colitis	3.95e-05	0.00164	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Prednisone—ulcerative colitis	3.91e-05	0.00162	CcSEcCtD
Vismodegib—Asthenia—Triamcinolone—ulcerative colitis	3.9e-05	0.00162	CcSEcCtD
Vismodegib—Abdominal pain—Betamethasone—ulcerative colitis	3.9e-05	0.00162	CcSEcCtD
Vismodegib—Abdominal pain—Dexamethasone—ulcerative colitis	3.9e-05	0.00162	CcSEcCtD
Vismodegib—Asthenia—Methylprednisolone—ulcerative colitis	3.89e-05	0.00161	CcSEcCtD
Vismodegib—Pruritus—Triamcinolone—ulcerative colitis	3.84e-05	0.0016	CcSEcCtD
Vismodegib—Pruritus—Methylprednisolone—ulcerative colitis	3.84e-05	0.00159	CcSEcCtD
Vismodegib—Dyspepsia—Prednisone—ulcerative colitis	3.78e-05	0.00157	CcSEcCtD
Vismodegib—Decreased appetite—Prednisone—ulcerative colitis	3.73e-05	0.00155	CcSEcCtD
Vismodegib—Rash—Prednisolone—ulcerative colitis	3.72e-05	0.00155	CcSEcCtD
Vismodegib—Dermatitis—Prednisolone—ulcerative colitis	3.72e-05	0.00154	CcSEcCtD
Vismodegib—Diarrhoea—Methylprednisolone—ulcerative colitis	3.71e-05	0.00154	CcSEcCtD
Vismodegib—Fatigue—Prednisone—ulcerative colitis	3.7e-05	0.00154	CcSEcCtD
Vismodegib—Constipation—Prednisone—ulcerative colitis	3.67e-05	0.00152	CcSEcCtD
Vismodegib—Vomiting—Hydrocortisone—ulcerative colitis	3.67e-05	0.00152	CcSEcCtD
Vismodegib—ABCB1—liver—ulcerative colitis	3.66e-05	0.00886	CbGeAlD
Vismodegib—Rash—Hydrocortisone—ulcerative colitis	3.64e-05	0.00151	CcSEcCtD
Vismodegib—Dermatitis—Hydrocortisone—ulcerative colitis	3.63e-05	0.00151	CcSEcCtD
Vismodegib—Asthenia—Dexamethasone—ulcerative colitis	3.54e-05	0.00147	CcSEcCtD
Vismodegib—Asthenia—Betamethasone—ulcerative colitis	3.54e-05	0.00147	CcSEcCtD
Vismodegib—Gastrointestinal pain—Prednisone—ulcerative colitis	3.51e-05	0.00146	CcSEcCtD
Vismodegib—Nausea—Prednisolone—ulcerative colitis	3.51e-05	0.00146	CcSEcCtD
Vismodegib—Pruritus—Dexamethasone—ulcerative colitis	3.49e-05	0.00145	CcSEcCtD
Vismodegib—Pruritus—Betamethasone—ulcerative colitis	3.49e-05	0.00145	CcSEcCtD
Vismodegib—Vomiting—Triamcinolone—ulcerative colitis	3.45e-05	0.00143	CcSEcCtD
Vismodegib—Vomiting—Methylprednisolone—ulcerative colitis	3.45e-05	0.00143	CcSEcCtD
Vismodegib—Nausea—Hydrocortisone—ulcerative colitis	3.43e-05	0.00142	CcSEcCtD
Vismodegib—Rash—Triamcinolone—ulcerative colitis	3.43e-05	0.00142	CcSEcCtD
Vismodegib—Dermatitis—Triamcinolone—ulcerative colitis	3.42e-05	0.00142	CcSEcCtD
Vismodegib—SMO—Signaling by GPCR—PTGER4—ulcerative colitis	3.42e-05	0.00203	CbGpPWpGaD
Vismodegib—Rash—Methylprednisolone—ulcerative colitis	3.42e-05	0.00142	CcSEcCtD
Vismodegib—Dermatitis—Methylprednisolone—ulcerative colitis	3.41e-05	0.00142	CcSEcCtD
Vismodegib—ALB—Response to elevated platelet cytosolic Ca2+—CALM3—ulcerative colitis	3.41e-05	0.00202	CbGpPWpGaD
Vismodegib—Abdominal pain—Prednisone—ulcerative colitis	3.39e-05	0.00141	CcSEcCtD
Vismodegib—Diarrhoea—Dexamethasone—ulcerative colitis	3.37e-05	0.0014	CcSEcCtD
Vismodegib—Diarrhoea—Betamethasone—ulcerative colitis	3.37e-05	0.0014	CcSEcCtD
Vismodegib—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	3.37e-05	0.00199	CbGpPWpGaD
Vismodegib—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	3.32e-05	0.00197	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	3.31e-05	0.00196	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—GHRL—ulcerative colitis	3.3e-05	0.00196	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CXCR1—ulcerative colitis	3.29e-05	0.00195	CbGpPWpGaD
Vismodegib—SHH—Disease—MAML2—ulcerative colitis	3.28e-05	0.00194	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—IL12B—ulcerative colitis	3.27e-05	0.00194	CbGpPWpGaD
Vismodegib—ALB—Vitamin B12 Metabolism—CRP—ulcerative colitis	3.26e-05	0.00193	CbGpPWpGaD
Vismodegib—Nausea—Triamcinolone—ulcerative colitis	3.23e-05	0.00134	CcSEcCtD
Vismodegib—Nausea—Methylprednisolone—ulcerative colitis	3.22e-05	0.00134	CcSEcCtD
Vismodegib—SHH—Signaling by GPCR—CALM3—ulcerative colitis	3.2e-05	0.00189	CbGpPWpGaD
Vismodegib—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	3.15e-05	0.00186	CbGpPWpGaD
Vismodegib—Vomiting—Dexamethasone—ulcerative colitis	3.13e-05	0.0013	CcSEcCtD
Vismodegib—Vomiting—Betamethasone—ulcerative colitis	3.13e-05	0.0013	CcSEcCtD
Vismodegib—SMO—Signaling by GPCR—GHRL—ulcerative colitis	3.13e-05	0.00185	CbGpPWpGaD
Vismodegib—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	3.13e-05	0.00185	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CXCR1—ulcerative colitis	3.12e-05	0.00185	CbGpPWpGaD
Vismodegib—Rash—Dexamethasone—ulcerative colitis	3.11e-05	0.00129	CcSEcCtD
Vismodegib—Rash—Betamethasone—ulcerative colitis	3.11e-05	0.00129	CcSEcCtD
Vismodegib—Dermatitis—Betamethasone—ulcerative colitis	3.11e-05	0.00129	CcSEcCtD
Vismodegib—Dermatitis—Dexamethasone—ulcerative colitis	3.11e-05	0.00129	CcSEcCtD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	3.08e-05	0.00182	CbGpPWpGaD
Vismodegib—Asthenia—Prednisone—ulcerative colitis	3.08e-05	0.00128	CcSEcCtD
Vismodegib—ABCB1—Allograft Rejection—CTLA4—ulcerative colitis	3.08e-05	0.00182	CbGpPWpGaD
Vismodegib—Pruritus—Prednisone—ulcerative colitis	3.04e-05	0.00126	CcSEcCtD
Vismodegib—SMO—Signaling by GPCR—CALM3—ulcerative colitis	3.03e-05	0.0018	CbGpPWpGaD
Vismodegib—ALB—SLC-mediated transmembrane transport—SLC22A4—ulcerative colitis	3.03e-05	0.00179	CbGpPWpGaD
Vismodegib—ALB—SLC-mediated transmembrane transport—SLC22A5—ulcerative colitis	3.03e-05	0.00179	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—PROCR—ulcerative colitis	3.01e-05	0.00178	CbGpPWpGaD
Vismodegib—ALB—Vitamin B12 Metabolism—ICAM1—ulcerative colitis	3e-05	0.00177	CbGpPWpGaD
Vismodegib—ABCG2—Fluoropyrimidine Activity—TP53—ulcerative colitis	2.99e-05	0.00177	CbGpPWpGaD
Vismodegib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	2.98e-05	0.00177	CbGpPWpGaD
Vismodegib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	2.98e-05	0.00176	CbGpPWpGaD
Vismodegib—Diarrhoea—Prednisone—ulcerative colitis	2.94e-05	0.00122	CcSEcCtD
Vismodegib—Nausea—Dexamethasone—ulcerative colitis	2.93e-05	0.00122	CcSEcCtD
Vismodegib—Nausea—Betamethasone—ulcerative colitis	2.93e-05	0.00122	CcSEcCtD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	2.92e-05	0.00173	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CCL20—ulcerative colitis	2.89e-05	0.00171	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CCL20—ulcerative colitis	2.74e-05	0.00162	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—ADRB2—ulcerative colitis	2.74e-05	0.00162	CbGpPWpGaD
Vismodegib—Vomiting—Prednisone—ulcerative colitis	2.73e-05	0.00113	CcSEcCtD
Vismodegib—SHH—Signaling Pathways—GNA12—ulcerative colitis	2.72e-05	0.00161	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—HLA-DQA1—ulcerative colitis	2.71e-05	0.0016	CbGpPWpGaD
Vismodegib—Rash—Prednisone—ulcerative colitis	2.71e-05	0.00112	CcSEcCtD
Vismodegib—Dermatitis—Prednisone—ulcerative colitis	2.7e-05	0.00112	CcSEcCtD
Vismodegib—SHH—Disease—CALM3—ulcerative colitis	2.7e-05	0.0016	CbGpPWpGaD
Vismodegib—CYP2C19—Melatonin metabolism and effects—NFKB1—ulcerative colitis	2.67e-05	0.00158	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—CRP—ulcerative colitis	2.65e-05	0.00157	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	2.61e-05	0.00155	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—ADRB2—ulcerative colitis	2.59e-05	0.00154	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—GNA12—ulcerative colitis	2.58e-05	0.00153	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CXCR2—ulcerative colitis	2.58e-05	0.00153	CbGpPWpGaD
Vismodegib—SHH—GPCR ligand binding—CXCL8—ulcerative colitis	2.57e-05	0.00152	CbGpPWpGaD
Vismodegib—Nausea—Prednisone—ulcerative colitis	2.55e-05	0.00106	CcSEcCtD
Vismodegib—ABCG2—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	2.49e-05	0.00148	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	2.49e-05	0.00148	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CXCR2—ulcerative colitis	2.44e-05	0.00145	CbGpPWpGaD
Vismodegib—SMO—GPCR ligand binding—CXCL8—ulcerative colitis	2.44e-05	0.00144	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—ICAM1—ulcerative colitis	2.44e-05	0.00144	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CCR6—ulcerative colitis	2.42e-05	0.00143	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—IL10—ulcerative colitis	2.39e-05	0.00142	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—ADCY5—ulcerative colitis	2.32e-05	0.00137	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—MAML2—ulcerative colitis	2.3e-05	0.00136	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CCR6—ulcerative colitis	2.3e-05	0.00136	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	2.29e-05	0.00135	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—GNA12—ulcerative colitis	2.28e-05	0.00135	CbGpPWpGaD
Vismodegib—ALB—Vitamin B12 Metabolism—IFNG—ulcerative colitis	2.28e-05	0.00135	CbGpPWpGaD
Vismodegib—ALB—Vitamin B12 Metabolism—RELA—ulcerative colitis	2.25e-05	0.00133	CbGpPWpGaD
Vismodegib—CYP2C8—Arachidonic acid metabolism—PTGS2—ulcerative colitis	2.23e-05	0.00132	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—ADCY5—ulcerative colitis	2.2e-05	0.0013	CbGpPWpGaD
Vismodegib—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	2.19e-05	0.0013	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—MAML2—ulcerative colitis	2.18e-05	0.00129	CbGpPWpGaD
Vismodegib—CYP2C8—Biological oxidations—PTGS1—ulcerative colitis	2.17e-05	0.00128	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—PTGER4—ulcerative colitis	2.13e-05	0.00126	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—CRP—ulcerative colitis	2.11e-05	0.00125	CbGpPWpGaD
Vismodegib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	2.07e-05	0.00123	CbGpPWpGaD
Vismodegib—ALB—Vitamin B12 Metabolism—IL1B—ulcerative colitis	2.03e-05	0.0012	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—PTGER4—ulcerative colitis	2.02e-05	0.0012	CbGpPWpGaD
Vismodegib—CYP2C19—Arachidonic acid metabolism—PTGS2—ulcerative colitis	1.99e-05	0.00118	CbGpPWpGaD
Vismodegib—SHH—Disease—ADCY5—ulcerative colitis	1.96e-05	0.00116	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—GHRL—ulcerative colitis	1.95e-05	0.00116	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	1.95e-05	0.00115	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—ICAM1—ulcerative colitis	1.94e-05	0.00115	CbGpPWpGaD
Vismodegib—CYP2C19—Biological oxidations—PTGS1—ulcerative colitis	1.94e-05	0.00115	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—HLA-DRB1—ulcerative colitis	1.93e-05	0.00114	CbGpPWpGaD
Vismodegib—ALB—Vitamin B12 Metabolism—NFKB1—ulcerative colitis	1.9e-05	0.00112	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CALM3—ulcerative colitis	1.89e-05	0.00112	CbGpPWpGaD
Vismodegib—ALB—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	1.89e-05	0.00112	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—RIPK2—ulcerative colitis	1.86e-05	0.0011	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—IFNG—ulcerative colitis	1.85e-05	0.0011	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—GHRL—ulcerative colitis	1.85e-05	0.0011	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—RELA—ulcerative colitis	1.83e-05	0.00108	CbGpPWpGaD
Vismodegib—CYP2C9—Arachidonic acid metabolism—PTGS2—ulcerative colitis	1.82e-05	0.00108	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CALM3—ulcerative colitis	1.79e-05	0.00106	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—RIPK2—ulcerative colitis	1.77e-05	0.00105	CbGpPWpGaD
Vismodegib—CYP2C9—Biological oxidations—PTGS1—ulcerative colitis	1.77e-05	0.00105	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—IL1B—ulcerative colitis	1.65e-05	0.000979	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—IL2—ulcerative colitis	1.65e-05	0.000976	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—ADRB2—ulcerative colitis	1.62e-05	0.000957	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—CALM3—ulcerative colitis	1.59e-05	0.000941	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	1.55e-05	0.000919	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—NFKB1—ulcerative colitis	1.54e-05	0.000914	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	1.54e-05	0.000911	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	1.54e-05	0.000911	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—ADRB2—ulcerative colitis	1.53e-05	0.000907	CbGpPWpGaD
Vismodegib—ALB—Vitamin B12 Metabolism—TNF—ulcerative colitis	1.48e-05	0.000874	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—IFNG—ulcerative colitis	1.47e-05	0.000872	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—RELA—ulcerative colitis	1.45e-05	0.000861	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—JAK2—ulcerative colitis	1.45e-05	0.000857	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—CHP1—ulcerative colitis	1.43e-05	0.000848	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—PTGS2—ulcerative colitis	1.41e-05	0.000836	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—IFNG—ulcerative colitis	1.41e-05	0.000833	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—JAK2—ulcerative colitis	1.37e-05	0.000812	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—ADCY5—ulcerative colitis	1.37e-05	0.000812	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	1.35e-05	0.000798	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	1.35e-05	0.000798	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—CXCL8—ulcerative colitis	1.32e-05	0.000782	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—IL1B—ulcerative colitis	1.31e-05	0.000778	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—CXCL8—ulcerative colitis	1.31e-05	0.000775	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—ADCY5—ulcerative colitis	1.3e-05	0.00077	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—IL2—ulcerative colitis	1.26e-05	0.000748	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—IL1B—ulcerative colitis	1.26e-05	0.000743	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—CXCL8—ulcerative colitis	1.25e-05	0.000741	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—IL2—ulcerative colitis	1.25e-05	0.00074	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—DLD—ulcerative colitis	1.24e-05	0.000732	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—NFKB1—ulcerative colitis	1.23e-05	0.000726	CbGpPWpGaD
Vismodegib—SHH—Disease—JAK2—ulcerative colitis	1.22e-05	0.000723	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—TNF—ulcerative colitis	1.2e-05	0.000711	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—IL2—ulcerative colitis	1.2e-05	0.000709	CbGpPWpGaD
Vismodegib—ALB—Vitamin B12 Metabolism—IL6—ulcerative colitis	1.19e-05	0.000705	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—GNA12—ulcerative colitis	1.18e-05	0.000697	CbGpPWpGaD
Vismodegib—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	1.16e-05	0.000689	CbGpPWpGaD
Vismodegib—SHH—Disease—CD4—ulcerative colitis	1.16e-05	0.000685	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—ITGAL—ulcerative colitis	1.16e-05	0.000684	CbGpPWpGaD
Vismodegib—SHH—Disease—PTGS2—ulcerative colitis	1.15e-05	0.00068	CbGpPWpGaD
Vismodegib—ALB—Platelet degranulation—TGFB1—ulcerative colitis	1.1e-05	0.000653	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—TP53—ulcerative colitis	1.06e-05	0.000627	CbGpPWpGaD
Vismodegib—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—ulcerative colitis	1.05e-05	0.000622	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—TGFB1—ulcerative colitis	9.76e-06	0.000578	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—IL6—ulcerative colitis	9.69e-06	0.000574	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	9.58e-06	0.000567	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—TNF—ulcerative colitis	9.54e-06	0.000565	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—TNF—ulcerative colitis	9.11e-06	0.000539	CbGpPWpGaD
Vismodegib—SHH—Disease—STAT3—ulcerative colitis	8.96e-06	0.000531	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	8.94e-06	0.000529	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CHP1—ulcerative colitis	8.89e-06	0.000526	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CHP1—ulcerative colitis	8.84e-06	0.000523	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—JAK2—ulcerative colitis	8.55e-06	0.000506	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	8.39e-06	0.000497	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	8.34e-06	0.000493	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	8.33e-06	0.000493	CbGpPWpGaD
Vismodegib—SHH—Disease—TGFB1—ulcerative colitis	8.31e-06	0.000492	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—RELA—ulcerative colitis	8.28e-06	0.00049	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	8.28e-06	0.00049	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—CALM3—ulcerative colitis	8.19e-06	0.000485	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—JAK2—ulcerative colitis	8.11e-06	0.00048	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CHP1—ulcerative colitis	7.93e-06	0.00047	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—RELA—ulcerative colitis	7.85e-06	0.000465	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CXCL8—ulcerative colitis	7.8e-06	0.000462	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CHP1—ulcerative colitis	7.74e-06	0.000458	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—IL6—ulcerative colitis	7.7e-06	0.000456	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—DLD—ulcerative colitis	7.67e-06	0.000454	CbGpPWpGaD
Vismodegib—ALB—Metabolism—DLD—ulcerative colitis	7.63e-06	0.000452	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—IL2—ulcerative colitis	7.46e-06	0.000442	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	7.43e-06	0.00044	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—IL6—ulcerative colitis	7.42e-06	0.000439	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CXCL8—ulcerative colitis	7.4e-06	0.000438	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CHP1—ulcerative colitis	7.23e-06	0.000428	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—JAK2—ulcerative colitis	7.19e-06	0.000425	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—IL2—ulcerative colitis	7.07e-06	0.000419	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—MMP9—ulcerative colitis	7.06e-06	0.000418	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—IL6—ulcerative colitis	7.04e-06	0.000417	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—NFKB1—ulcerative colitis	6.98e-06	0.000413	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—DLD—ulcerative colitis	6.85e-06	0.000405	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	6.78e-06	0.000401	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—MMP9—ulcerative colitis	6.69e-06	0.000396	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—DLD—ulcerative colitis	6.68e-06	0.000396	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	6.66e-06	0.000394	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—NFKB1—ulcerative colitis	6.62e-06	0.000392	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—STAT3—ulcerative colitis	6.28e-06	0.000372	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—IL2—ulcerative colitis	6.27e-06	0.000371	CbGpPWpGaD
Vismodegib—SHH—Disease—IL6—ulcerative colitis	6.26e-06	0.000371	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—DLD—ulcerative colitis	6.24e-06	0.00037	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PTGS1—ulcerative colitis	5.98e-06	0.000354	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—STAT3—ulcerative colitis	5.95e-06	0.000352	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—TGFB1—ulcerative colitis	5.82e-06	0.000344	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	5.78e-06	0.000342	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—ALB—ulcerative colitis	5.59e-06	0.000331	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—TGFB1—ulcerative colitis	5.52e-06	0.000327	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	5.51e-06	0.000326	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—CALM3—ulcerative colitis	5.38e-06	0.000319	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—MMP1—ulcerative colitis	5.26e-06	0.000311	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	5.14e-06	0.000305	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	4.89e-06	0.000289	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	4.81e-06	0.000285	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—TP53—ulcerative colitis	4.79e-06	0.000284	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CHP1—ulcerative colitis	4.77e-06	0.000282	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—TP53—ulcerative colitis	4.54e-06	0.000269	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	4.51e-06	0.000267	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	4.5e-06	0.000266	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—IL6—ulcerative colitis	4.38e-06	0.00026	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—ABCB1—ulcerative colitis	4.18e-06	0.000248	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—IL6—ulcerative colitis	4.16e-06	0.000246	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—DLD—ulcerative colitis	4.12e-06	0.000244	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	4.06e-06	0.00024	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	4.03e-06	0.000239	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	3.96e-06	0.000235	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—ADCY5—ulcerative colitis	3.9e-06	0.000231	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PTGS1—ulcerative colitis	3.71e-06	0.00022	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—JAK2—ulcerative colitis	3.7e-06	0.000219	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PTGS1—ulcerative colitis	3.69e-06	0.000218	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	3.65e-06	0.000216	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	3.62e-06	0.000214	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CALM3—ulcerative colitis	3.34e-06	0.000198	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CALM3—ulcerative colitis	3.32e-06	0.000197	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PTGS1—ulcerative colitis	3.31e-06	0.000196	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	3.3e-06	0.000195	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	3.26e-06	0.000193	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PTGS1—ulcerative colitis	3.23e-06	0.000191	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—IL2—ulcerative colitis	3.23e-06	0.000191	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	3.19e-06	0.000189	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	3.17e-06	0.000188	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	3.02e-06	0.000179	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PTGS1—ulcerative colitis	3.02e-06	0.000179	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CALM3—ulcerative colitis	2.98e-06	0.000176	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	2.97e-06	0.000176	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PPARG—ulcerative colitis	2.91e-06	0.000172	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CALM3—ulcerative colitis	2.91e-06	0.000172	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	2.85e-06	0.000169	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CALM3—ulcerative colitis	2.72e-06	0.000161	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—ALB—ulcerative colitis	2.62e-06	0.000155	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	2.6e-06	0.000154	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ABCB1—ulcerative colitis	2.6e-06	0.000154	CbGpPWpGaD
Vismodegib—ALB—Metabolism—ABCB1—ulcerative colitis	2.58e-06	0.000153	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—TGFB1—ulcerative colitis	2.52e-06	0.000149	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ADCY5—ulcerative colitis	2.42e-06	0.000143	CbGpPWpGaD
Vismodegib—ALB—Metabolism—ADCY5—ulcerative colitis	2.41e-06	0.000143	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ABCB1—ulcerative colitis	2.32e-06	0.000137	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PTGS2—ulcerative colitis	2.29e-06	0.000136	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ADCY5—ulcerative colitis	2.16e-06	0.000128	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ABCB1—ulcerative colitis	2.11e-06	0.000125	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ADCY5—ulcerative colitis	2.11e-06	0.000125	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—TP53—ulcerative colitis	2.07e-06	0.000123	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PTGS1—ulcerative colitis	1.99e-06	0.000118	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ADCY5—ulcerative colitis	1.97e-06	0.000117	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PPARG—ulcerative colitis	1.81e-06	0.000107	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PPARG—ulcerative colitis	1.8e-06	0.000106	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CALM3—ulcerative colitis	1.79e-06	0.000106	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ALB—ulcerative colitis	1.62e-06	9.62e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PPARG—ulcerative colitis	1.61e-06	9.55e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PPARG—ulcerative colitis	1.57e-06	9.32e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PPARG—ulcerative colitis	1.47e-06	8.71e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ALB—ulcerative colitis	1.45e-06	8.59e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PTGS2—ulcerative colitis	1.42e-06	8.42e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ALB—ulcerative colitis	1.42e-06	8.38e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PTGS2—ulcerative colitis	1.41e-06	8.37e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ABCB1—ulcerative colitis	1.39e-06	8.25e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ALB—ulcerative colitis	1.32e-06	7.83e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ADCY5—ulcerative colitis	1.3e-06	7.7e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PTGS2—ulcerative colitis	1.27e-06	7.51e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PTGS2—ulcerative colitis	1.24e-06	7.33e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PTGS2—ulcerative colitis	1.16e-06	6.85e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PPARG—ulcerative colitis	9.7e-07	5.74e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ALB—ulcerative colitis	8.72e-07	5.16e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PTGS2—ulcerative colitis	7.63e-07	4.52e-05	CbGpPWpGaD
